Ventyx Biosciences Engages in Key Investor Conferences
![Ventyx Biosciences Engages in Key Investor Conferences](https://investorshangout.com/images/blog/ihnews-Ventyx%20Biosciences%20Engages%20in%20Key%20Investor%20Conferences.jpg)
Ventyx Biosciences Engages in Key Investor Conferences
Ventyx Biosciences, Inc. (Nasdaq: VTYX), a clinical-stage biopharmaceutical company dedicated to advancing innovative oral therapies, is on a mission to address significant unmet medical needs in the field of inflammatory diseases. The company has announced that its executives will participate in several important investor conferences in the near future.
Upcoming Investor Conferences
The first major event is the 2024 Wells Fargo Healthcare Conference where Ventyx will showcase insights into their operations. This event is scheduled to take place on September 4. The presentation will occur from 11:00 to 11:35 AM ET. Investors and interested parties can follow this event closely to gain insights into Ventyx's strategic direction.
Wells Fargo Healthcare Conference Details
Event: 2024 Wells Fargo Healthcare Conference
Time: 11:00 - 11:35 AM ET
Morgan Stanley Global Healthcare Conference
Following the Wells Fargo Conference, Ventyx will also be participating in the Morgan Stanley 22nd Annual Global Healthcare Conference. This event is vital for stakeholders looking to understand the company's role in the healthcare market and will occur on September 6 from 1:05 to 1:40 PM ET. These presentations are pivotal for informing investors about Ventyx's future plans and financial health.
Morgan Stanley Conference Details
Event: Morgan Stanley 22nd Annual Global Healthcare Conference
Time: 1:05 - 1:40 PM ET
Webcast Availability
Ventyx Biosciences will provide a live webcast of the presentations from both conferences. This will allow investors who cannot attend in person to engage with the material. Those interested can find the webcast in the Investors and News section on Ventyx's official website. A replay of each session will also be available for thirty days following the conclusion of the events, ensuring all interested parties can access the crucial information shared.
About Ventyx Biosciences
Ventyx Biosciences is focused on pioneering novel oral therapies aimed at treating inflammatory diseases. The company believes that by efficiently discovering and developing unique drug candidates, they can lead the shift from injectable to oral medications within this therapeutic area. Their current pipeline includes programs targeting NLRP3, S1P1R, and TYK2, positioning Ventyx to be at the forefront of innovations in oral therapies for both peripheral and neuroinflammatory conditions.
Investor Relations
For more information about Ventyx's mission, product pipeline, and corporate strategies, investors are encouraged to reach out directly. The contact for investor relations is Patti Bank, Managing Director at ICR Westwicke. She can be reached at (415) 513-1284 or via email at IR@ventyxbio.com.
Frequently Asked Questions
What is Ventyx Biosciences known for?
Ventyx Biosciences focuses on developing novel oral therapies for inflammatory diseases with significant unmet medical needs.
When are the upcoming investor conferences?
The Wells Fargo Healthcare Conference is on September 4, and the Morgan Stanley Global Healthcare Conference is on September 6.
How can investors access the presentations?
Investors can watch a live webcast of the presentations on Ventyx’s website, with replays available for thirty days after each event.
Who can investors contact for more information?
Patti Bank, Managing Director at ICR Westwicke, can be contacted at (415) 513-1284 or via email at IR@ventyxbio.com.
What therapeutic areas does Ventyx concentrate on?
Ventyx specializes in oral therapies targeting conditions related to inflammation, specifically focusing on peripheral and neuroinflammatory diseases.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Coiled Tubing Market to Reach $6.5 Billion Driven by Innovation
- Challenges and Advances in Sickle Cell Disease Treatments
- Comun Expands Services with New Funding for Immigrant Support
- NewtekOne, Inc. CEO Barry Sloane to Attend Key Conference
- Blink Charging Announces Leadership Transition
- AUGA group, AB Investor Conference Webinar Details
- Public Opening Position Disclosure by Rathbones Group Plc
- Loupe Offers Exciting Rewards for Topps Chrome Basketball
- Pinpoint Digital, LLC Transforms Online Presence with New Website
- Verizon Home Internet Claims Reviewed by NAD